Reggio Emilia, January 26th, 2021
Reggio Emilia, October 26th, 2020
From: Agostino Barazza, Chief Executive Officer, ICE Group
To: All customers
Dear Customers and Partners,
I hope this letter is finding you well and safe.
As you certainly know, COVID-19 situation is continuously evolving in Italy, in Europe and worldwide. The global number of COVID-19 cases and, unfortunately, deceases have in fact been significantly increasing since the beginning of this second pandemic wave.
MILAN, August 17th, 2020
– Industria Chimica Emiliana (“ICE”), a global leader in the production of Ursodeoxycholic Acid (“UDCA”), an active pharmaceutical ingredient (“API”) primarily used in drugs that treat gastroenterological diseases, has acquired New Zealand Pharmaceuticals Ltd (“NZP”). As part of the transaction, funds managed and/or advised by Archer Capital (former NZP majority shareholders) will become shareholders of ICE.